Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	1/27/2006 12:30:07 PM
	Read Replies (1) of 3044

Millennium Pharmaceuticals "neutral," target price raised Friday, January 27, 2006 9:07:23 AM ET Robert W. Baird NEW YORK, January 27 (newratings.com) - Analysts at Robert W Baird reiterate their "neutral" rating on Millennium Pharmaceuticals Inc (MLNM.NAS), while raising their estimates for the company. The target price has been raised from $9 to $10. In a research note published this morning, the analysts mention that company has reported its 4Q05 EPS in-line with and sales short of the estimates. Millennium Pharmaceuticals’ earnings for the quarter were boosted by strategic alliance revenues and higher-than-anticipated product royalties, which offset high spending, the analysts say. The EPS estimate for 2008 has been raised from $0.24 to $0.29 to reflect a potential reduction in R&D spending.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next